Barcelona, February 2 2018

New horizons and current controversies in immuno-oncology

II immunoclinicsummit 2018

New horizons and current controversies in immuno-oncology

ORGANIZATION Dr. Ana Arance and Dr. Aleix Prat, Medical Oncology Department Hospital Clínic de Barcelona

Esteve Auditorium, Esther Koplowitz Centre (CEK)
Friday, February 2, 2018

Response and resistance to anti-PD-1. Dr. Toni Ribas, Associate Professor at the University of California Los Angeles (UCLA), Director of the Tumor Immunology program at the Jonsson Comprehensive Cancer Center (JCCC) and Chair of the Melanoma Committee at SWOG, Los Angeles.
The impact of gut microbiota on the efficacy of immunotherapy. Dr. Paula Roberti, Researcher at the Immunology and Immunotherapy Laboratory group at the Institut Gustave Roussy, Villejuif.
Deciphering the role of Fc/FcR interaction in the activity of Immunomodulatory antibodies. Dr. Sergio Quezada, Principal Investigator of the Immune Regulation and Tumour Immunotherapy Research group at the University College London (UCL), London.
Rational design of Immunecheckpoint combinations. Dr. Toni Ribas, Associate Professor at the University of California Los Angeles (UCLA), Director of the Tumor Immunology program at the Jonsson Comprehensive Cancer Center (JCCC) and Chair of the Melanoma Committee at SWOG, Los Angeles.
Harnessing NK cell-mediated ADCC in HER2+ breast Cancer. Dr. Aura Muntasell, Researcher of the Immunology Unit at the Institut de Recerca de l’Hospital del Mar (IMIM-Parc de Salut Mar), Barcelona.
Personalized T cell therapies targeting the mutanome. Dr. Alena Gros, Principal Investigator of the Tumor Immunology and Immunotherapy group at the Vall d’Hebron Institut d’Oncologia (VHIO), Barcelona.
Cancer cell-immunotherapy in cancer: Will CARTs provide the best driving to success? Dr. Manel Juan, Head of Seccion of Immunopathology at the Hospital Clínic de Barcelona, Barcelona.
Final Remarks.

Sponsors

AstraZeneca Bristol-Myers Squibb MSD nanostring Roche Novartis Merck pfizer

Scientific endorsement from

solti getica seom

Technical secretary

Aula clínic

Tel: 93 227 98 52

Bcnscience